Hogy Medical Co.,Ltd.
Stock Price Chart
2026/05/15 UpdatedPrice Trend
2026/05/15 UpdatedPrice & Trading Details
2026/05/15 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/06/05Shareholder Composition
Updated 2026/06/05Major Holders
Updated 2026/06/05| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
250.8K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
164.5K | +3.33% | |
|
GMO TRUST-GMO Implementation Fund
|
137.4K | 0.00% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap
|
64.7K | 0.00% | |
|
GMO TRUST-GMO Benchmark-Free Fund
|
65.0K | 0.00% | |
|
VANGUARD WHITEHALL Fd.S-Vanguard Intl Dividend Appreciation Index Fd.
|
42.5K | +1.43% |
Dividend History
Updated 2026/06/04| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥68 | -15.6% |
| 2024 | ¥80 | +2.6% |
| 2023 | ¥78 | +11.4% |
| 2022 | ¥70 | +2.9% |
| 2021 | ¥68 | - |
Financial Performance
2026/06/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥36,778M | ¥38,981M | ¥39,100M | ¥39,138M |
| Gross Profit | ¥15,416M | ¥15,740M | ¥13,063M | ¥12,621M |
| Operating Income | ¥6,135M | ¥6,635M | ¥4,169M | ¥3,811M |
| Pretax Income | ¥6,292M | ¥6,218M | ¥4,098M | ¥3,004M |
| Net Income | ¥4,370M | ¥4,316M | ¥2,804M | ¥1,520M |
| EPS | ¥153.00 | ¥177.95 | ¥115.57 | - |
| Operating Margin | 16.68% | 17.02% | 10.66% | 9.74% |
| Balance Sheet | ||||
| Total Assets | ¥98,967M | ¥102,180M | ¥100,041M | ¥97,895M |
| Total Equity | ¥79,957M | ¥83,606M | ¥86,110M | ¥74,323M |
| Total Liabilities | ¥19,010M | ¥18,574M | ¥13,931M | ¥23,572M |
| Cash | ¥14,364M | ¥18,862M | ¥19,419M | ¥22,005M |
| Interest-bearing Debt | ¥10,003M | ¥8,890M | ¥5,823M | ¥13,789M |
| Equity Ratio | 80.79% | 81.82% | 86.07% | 75.92% |
| D/E Ratio | 0.13 | 0.11 | 0.07 | 0.19 |
| Cash Flow | ||||
| Operating CF | ¥8,501M | ¥9,176M | ¥7,117M | ¥11,555M |
| Investing CF | -¥3,812M | -¥1,951M | -¥3,262M | -¥3,917M |
| Financing CF | -¥11,049M | -¥3,142M | -¥3,892M | -¥5,455M |
| Free CF | ¥5,300M | ¥7,784M | ¥4,316M | ¥6,248M |
| Efficiency | ||||
| ROE | 5.47% | 5.16% | 3.26% | 2.05% |
| ROA | 4.42% | 4.22% | 2.80% | 1.55% |
Latest IR Information
-
[Hokigem Medical] Notice of Delisting | May 2026
Hokigem Medical Co., Ltd. announced that it will delist from the stock exchange on May 15, 2026, expressing gratitude to shareholders for their long-term support.
Read more -
Notice Regarding Approval Resolution on Share Consolidation, Abolition of the Number of Shares per Unit, and Partial Amendment of Articles of Incorporation
Consolidated 22,535,460 common shares into 1 share, reducing the total number of issued shares to 3. Following the share consolidation, delisting from the Tokyo Stock Exchange Prime Market is scheduled for May 15, 2026.
Read more -
Notice Regarding Cancellation of Treasury Stock
Hogi Medical Co., Ltd. plans to cancel 976,397 shares of treasury stock on May 18, 2026. The cancellation is contingent upon approval of a stock consolidation at the extraordinary shareholders meeting.
Read more -
Notice of Extraordinary General Meeting of Shareholders Regarding Share Consolidation, Abolition of the Number of Shares per Unit, and Partial Amendment of the Articles of Incorporation
Scheduled to delist on May 15, 2026. The share consolidation will consolidate 7,186,355 shares into one share, reducing the total number of issued shares from 22,535,463 to 3 shares. The tender offer price is 6,700 yen per share, and the...
Read more -
Announcement Regarding the Results of the Tender Offer by TCG2509 Inc. for Our Shares and Changes in Parent Company, Major Shareholders and the Largest Major Shareholder
The tender offer by TCG2509 Inc. for 18,892,230 shares of Hogi Medical Co., Ltd. has been completed, and the company is expected to become the parent company and the largest major shareholder effective March 9, 2026.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥4,400
Rating Score: 3.00 (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Hogy Medical Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of medical consumables, medical equipment, and medical nonwoven products in Japan. The company offers surgical kit products; sterilization products comprising Mekkin bags sterilization pouches and sterilization containers; non-woven fabric products; remanufactured single-use devices; operation support related, such as operating room management services, OPENO, case studies services, and OPERA-Compass and narcotics and poisons box. It also provides minimally invasive treatment products, including SuReFInD for assistance in the excision of small-cell lung cancer in pneumonectomy operations; EMARO, an endoscope holder; SECUREA, a sponge for endoscopic surgery; and personal protective equipment related products. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was incorporated in 1961 and is headquartered in Tokyo, Japan. As of March 2, 2026, Hogy Medical Co.,Ltd. operates as subsidiary of The Carlyle Group Inc.
